Terms ending in 2035
Every in-force patent on Pharma Cinq, LLC's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,175,295 | Antibodies and Methods for the Detection of Cell Death In force · High confidence | PDL Biopharma, Inc. | In force | High confidence | |
| US 10,401,368 | Antibodies and Methods for the Detection of Cell Death In force (reinstated) · High confidence | Pharma Cinq, LLC | In force (reinstated) | High confidence | |
| US 11,061,028 | Compositions and Methods for the Diagnosis of Lyme Disease In force · High confidence | Pharma Cinq, LLC | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Pharma Cinq, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.